Next Article in Journal
Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour
Previous Article in Journal
Kissing and hpv: Honest Popular Visions, the Human Papilloma Virus, and Cancers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 21
Issue 3
10.3747/co.21.1849
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma

by
P. Le
1,*,
A. Garg
1,
G. Brandao
2,
A. Abu-Sanad
1 and
L. Panasci
1
1
Department of Medical Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada
2
Department of Pathology, Jewish General Hospital, McGill University, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(3), 518-520; https://doi.org/10.3747/co.21.1849
Submission received: 5 March 2014 / Revised: 9 April 2014 / Accepted: 13 May 2014 / Published: 1 June 2014

Abstract

Perivascular epithelioid cell tumours (PEComas) are rare mesenchymal tumours. Some have a benign course; others metastasize. Treatment of malignant PEComas is challenging, and little is known about treatment for patients with metastatic disease. Here, we report a case of metastatic malignant PEComa with estrogen and progesterone receptor expression that showed a favourable and sustained response to letrozole.
Keywords: malignant pecoma; pecoma; receptors; estrogen; progesterone; metastasis; letrozole; sirolimus malignant pecoma; pecoma; receptors; estrogen; progesterone; metastasis; letrozole; sirolimus

Share and Cite

MDPI and ACS Style

Le, P.; Garg, A.; Brandao, G.; Abu-Sanad, A.; Panasci, L. Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma. Curr. Oncol. 2014, 21, 518-520. https://doi.org/10.3747/co.21.1849

AMA Style

Le P, Garg A, Brandao G, Abu-Sanad A, Panasci L. Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma. Current Oncology. 2014; 21(3):518-520. https://doi.org/10.3747/co.21.1849

Chicago/Turabian Style

Le, P., A. Garg, G. Brandao, A. Abu-Sanad, and L. Panasci. 2014. "Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma" Current Oncology 21, no. 3: 518-520. https://doi.org/10.3747/co.21.1849

APA Style

Le, P., Garg, A., Brandao, G., Abu-Sanad, A., & Panasci, L. (2014). Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma. Current Oncology, 21(3), 518-520. https://doi.org/10.3747/co.21.1849

Article Metrics

Back to TopTop